ROME Therapeutics logo

ROME Therapeutics, Inc.

Biotechnology

ROME Therapeutics Stock

ROME Therapeutics focuses on discovering and developing novel therapies for cancer and autoimmune diseases. ROME’s research revolves around the exploration of the repeatome—a vast and uncharted portion of the human genome comprised of repetitive sequences—to uncover new molecular insights into disease mechanisms.

Management Team

Rosana Kapeller, MD, PhD Co-founder, President and CEO
Heike Keilhack, PhD Chief Scientific Officer
Kyle Kuvalanka CFO and Chief Business Officer

Funding Information